Research programme: type 1 diabetes vaccine - Vaxine
Latest Information Update: 20 Apr 2010
At a glance
- Originator Vaxine
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 27 Nov 2006 Preclinical trials in Diabetes mellitus in Australia (Injection)
- 27 Nov 2006 Vaxine is seeking development partners for the type 1 diabetes vaccine candidate